Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Citation

  • Authors: Depreter, B., Weening, K. E., Vandepoele, K., Essand, M., De Moerloose, B., Themeli, M., Cloos, J., Hanekamp, D., Moors, I., D' Hont I, Denys, B., Uyttebroeck, A., Van Damme, A., Dedeken, L., Snauwaert, S., Goetgeluk, G., De Munter, S., Kerre, T., Vandekerckhove, B., Lammens, T., Philippe, J.
  • Year: 2019
  • Journal: Haematologica
  • Applications: in vitro / DNA / jetPEI
  • Cell type: HEK-293FT

Method

Lentivirus production

Abstract

Immunotherapeutic strategies targeting the rare leukemic stem cell compartment might provide salvage to the high relapse rates currently observed in acute myeloid leukemia. We applied gene expression profiling for comparison of leukemic blasts and leukemic stem cells with their normal counterparts. Here, we show that the T-cell receptor gamma chain alternate reading frame protein (TARP) is overexpressed in de novo pediatric (n=13) and adult (n=17) acute myeloid leukemia sorted leukemic stem cells and blasts compared to hematopoietic stem cells and normal myeloblasts (15 healthy controls). Moreover, TARP expression was significantly associated with a fms-like tyrosine kinase receptor-3 internal tandem duplications in pediatric acute myeloid leukemia. TARP overexpression was confirmed in acute myeloid leukemia cell lines (n=9), and was found to be absent in B-cell acute lymphocytic leukemia (n=5) and chronic myeloid leukemia (n=1). Sequencing revealed that both a classical TARP transcript, as described in breast and prostate adenocarcinoma, and an acute myeloid leukemia-specific alternative TARP transcript, were present. Protein expression levels mostly matched transcript levels. TARP was shown to reside in the cytoplasmic compartment and showed sporadic endoplasmatic reticulum co-localization. TARP-T-cell receptor engineered cytotoxic T-cells in vitro killed acute myeloid leukemia cell lines and patient leukemic cells co-expressing TARP and HLA-A*0201. In conclusion, TARP qualifies as a relevant target for immunotherapeutic T-cell therapy in acute myeloid leukemia.

Go to